WMSA
TLOG

Weiss Multi-Strategy Advisers’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio TLOG Stock Details TLOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-31,500
Closed -$54K – 589
2015
Q4 		$54K Hold
31,500
– – ﹤0.01% 378
2015
Q3 		$59K Buy
+31,500
New +$75K ﹤0.01% 384

Other funds holding TLOG

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GA
Geneva Advisors Chicago, Illinois $5.81B AUM 23.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Weiss Multi-Strategy Advisers's TLOG Position: Q1 2016 in Review

Weiss Multi-Strategy Advisers sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q1 2016, closing a stake of 31,500 shares — an estimated $54K sold.

Weiss Multi-Strategy Advisers first reported a position in TLOG in Q3 2015 and held it in 2 quarters. The position peaked at $59K in Q3 2015. 25 funds tracked by Wall St. Rank hold TLOG as of Q1 2016.

  • Weiss Multi-Strategy Advisers reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q1 2016 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 31,500 TetraLogic Pharmaceuticals Corporation shares in Q1 2016, an estimated $54K.
  • Weiss Multi-Strategy Advisers first reported a position in TetraLogic Pharmaceuticals Corporation in Q3 2015 and held it in 2 quarters.
  • Weiss Multi-Strategy Advisers's TetraLogic Pharmaceuticals Corporation position peaked at $59K in Q3 2015.
  • 25 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q1 2016.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2016, filed 16 May 2016.